Postnatal analgesic effects of racemic methadone and its isomers in 129/SvEv and CD-1 mouse pups.

Item

Title
Postnatal analgesic effects of racemic methadone and its isomers in 129/SvEv and CD-1 mouse pups.
Identifier
AAI3159197
identifier
3159197
Creator
Baliram, Ramkumarie.
Contributor
Adviser: Gordon A. Barr
Date
2005
Language
English
Publisher
City University of New York.
Subject
Psychology, Psychobiology | Biology, Neuroscience
Abstract
Experiment one. The postnatal analgesic effects of racemic methadone and its isomers in the 129/SvEv and CD-1 mouse pups in the formalin test were studied. The CD-1 pups were used as a control as the 129/SvEv mouse has been reported to have putative deficits of the mu-opioid or NMDA receptors. Fifteen minutes post drug injection pups were injected with dilute formalin and behavioral responses were observed for 45 minutes. dl-Methadone and its enantiomers resulted in greater analgesic effectiveness at, PD 3 and 10 than at PD 21. Also, l- and dl-methadone were effective analgesics, in both phases of the formalin test and d-methadone was only minimally effective in the second phase.;Experiment two. The postnatal analgesic effects of racemic methadone and its isomers in the 129/SvEv and the CD-1 mouse pups in the thermal test were studied. Pups were injected with either vehicle or each of four doses of either: d-, l- or dl-methadone in a cumulative dose response paradigm. Thirty minutes post-drug injection, appendage withdrawal latencies were taken as indicators of nociception. Results showed that all drugs were more effective at PD 3 than at PD 21. dl-Methadone exerted potentiated analgesia at the younger ages tested but not at PD 21, suggesting an interaction of the mu-opioid and the NMDA receptors. The analgesic effects exerted by dl-methadone at PD 21, are consistent with those of adults where 1-methadone was more effective than dl-methadone and d-methadone was the least effective drug tested.;Experiment three. Morphine and MK801 were co-administered to mimic the potentiated effects of dl-methadone at PD 3 and 10. MK801 did not potentiate the analgesic effects of morphine in both mouse strains, suggesting the mu-opioid and the NMDA receptors were not interacting in dl-methadone potentiated analgesia. There was no evidence that the NMDA receptor was playing a role in the potentiated analgesic effects of dl-methadone and d-methadone, as MK801 was not an effective analgesic. d-Methadone likely exerted minimal analgesic effects in phasic and tonic nociception at other receptors, other than the NMDA receptors.
Type
dissertation
Source
PQT Legacy CUNY.xlsx
degree
Ph.D.
Item sets
CUNY Legacy ETDs